glp 1 agonist hypothyroidism Microdosing GLP-1 for Hashimoto's: Evidence, Risks and NHS Guidance – Bolt Pharmacy Patients Who Lose Weight After
Description
10.3389/fcdhc.2023.1293926 [DOI] [PMC free article] [PubMed] [Google Scholar] 90.Angiolillo DJ, et al
10.1016/S2213-8587(22)00008-0 38 KakuK.RasmussenM
Under hyperglycaemic conditions they additionally inhibit glucagon secretion
doi: 10.3390/ijms20081940 77 BaiFZhangLHZhangWWZhengRHEskewJRBennettJet al
The two primary endpoints were the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS, which ranges from 0 to 100) and the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)
92% of patients achieved more than 10% weight loss compared to 10% on diet and exercise counselling alone
